Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 0.63
PDII's Cash to Debt is ranked lower than
62% of the 726 Companies
in the Global Business Services industry.

( Industry Median: 1.75 vs. PDII: 0.63 )
Ranked among companies with meaningful Cash to Debt only.
PDII' s 10-Year Cash to Debt Range
Min: 0.63  Med: 10000.00 Max: No Debt
Current: 0.63
Equity to Asset 0.15
PDII's Equity to Asset is ranked lower than
88% of the 671 Companies
in the Global Business Services industry.

( Industry Median: 0.49 vs. PDII: 0.15 )
Ranked among companies with meaningful Equity to Asset only.
PDII' s 10-Year Equity to Asset Range
Min: -0.09  Med: 0.65 Max: 0.81
Current: 0.15
-0.09
0.81
F-Score: 3
Z-Score: -0.38
M-Score: 1.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -11.84
PDII's Operating margin (%) is ranked lower than
85% of the 723 Companies
in the Global Business Services industry.

( Industry Median: 5.44 vs. PDII: -11.84 )
Ranked among companies with meaningful Operating margin (%) only.
PDII' s 10-Year Operating margin (%) Range
Min: -43.69  Med: -1.99 Max: 9.86
Current: -11.84
-43.69
9.86
Net-margin (%) -14.61
PDII's Net-margin (%) is ranked lower than
86% of the 724 Companies
in the Global Business Services industry.

( Industry Median: 3.65 vs. PDII: -14.61 )
Ranked among companies with meaningful Net-margin (%) only.
PDII' s 10-Year Net-margin (%) Range
Min: -41.75  Med: -5.06 Max: 8.21
Current: -14.61
-41.75
8.21
ROE (%) -74.59
PDII's ROE (%) is ranked lower than
96% of the 684 Companies
in the Global Business Services industry.

( Industry Median: 8.38 vs. PDII: -74.59 )
Ranked among companies with meaningful ROE (%) only.
PDII' s 10-Year ROE (%) Range
Min: -61.11  Med: -9.44 Max: 39.76
Current: -74.59
-61.11
39.76
ROA (%) -22.05
PDII's ROA (%) is ranked lower than
89% of the 737 Companies
in the Global Business Services industry.

( Industry Median: 3.56 vs. PDII: -22.05 )
Ranked among companies with meaningful ROA (%) only.
PDII' s 10-Year ROA (%) Range
Min: -26.61  Med: -5.82 Max: 21.83
Current: -22.05
-26.61
21.83
ROC (Joel Greenblatt) (%) -496.66
PDII's ROC (Joel Greenblatt) (%) is ranked lower than
93% of the 721 Companies
in the Global Business Services industry.

( Industry Median: 22.09 vs. PDII: -496.66 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PDII' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1034.1  Med: -110.87 Max: 600
Current: -496.66
-1034.1
600
Revenue Growth (3Y)(%) -9.60
PDII's Revenue Growth (3Y)(%) is ranked lower than
84% of the 551 Companies
in the Global Business Services industry.

( Industry Median: 4.70 vs. PDII: -9.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PDII' s 10-Year Revenue Growth (3Y)(%) Range
Min: -30.9  Med: -0.80 Max: 64.7
Current: -9.6
-30.9
64.7
EBITDA Growth (3Y)(%) 89.60
PDII's EBITDA Growth (3Y)(%) is ranked higher than
98% of the 461 Companies
in the Global Business Services industry.

( Industry Median: 5.90 vs. PDII: 89.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PDII' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -100  Med: -12.90 Max: 107.3
Current: 89.6
-100
107.3
EPS Growth (3Y)(%) 34.30
PDII's EPS Growth (3Y)(%) is ranked higher than
84% of the 417 Companies
in the Global Business Services industry.

( Industry Median: 6.30 vs. PDII: 34.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PDII' s 10-Year EPS Growth (3Y)(%) Range
Min: -52.5  Med: -11.40 Max: 44.9
Current: 34.3
-52.5
44.9
» PDII's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

PDII Guru Trades in Q2 2014

Jim Simons 530,900 sh (+0.99%)
Chuck Royce 810,622 sh (-8.42%)
» More
Q3 2014

PDII Guru Trades in Q3 2014

Jim Simons 547,600 sh (+3.15%)
Chuck Royce 630,848 sh (-22.18%)
» More
Q4 2014

PDII Guru Trades in Q4 2014

Jim Simons 668,300 sh (+22.04%)
Chuck Royce 65,383 sh (unchged)
Chuck Royce 65,383 sh (-89.64%)
Chuck Royce 65,383 sh (-89.64%)
» More
Q1 2015

PDII Guru Trades in Q1 2015

Chuck Royce Sold Out
Jim Simons 652,640 sh (-2.34%)
» More
» Details

Insider Trades

Latest Guru Trades with PDII

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 8.44
PDII's Forward P/E is ranked higher than
89% of the 273 Companies
in the Global Business Services industry.

( Industry Median: 15.87 vs. PDII: 8.44 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 1.39
PDII's P/B is ranked higher than
67% of the 684 Companies
in the Global Business Services industry.

( Industry Median: 2.38 vs. PDII: 1.39 )
Ranked among companies with meaningful P/B only.
PDII' s 10-Year P/B Range
Min: 0.41  Med: 1.39 Max: 3.36
Current: 1.39
0.41
3.36
P/S 0.17
PDII's P/S is ranked higher than
95% of the 750 Companies
in the Global Business Services industry.

( Industry Median: 1.34 vs. PDII: 0.17 )
Ranked among companies with meaningful P/S only.
PDII' s 10-Year P/S Range
Min: 0.12  Med: 0.69 Max: 1.43
Current: 0.17
0.12
1.43
Current Ratio 1.27
PDII's Current Ratio is ranked lower than
66% of the 686 Companies
in the Global Business Services industry.

( Industry Median: 1.54 vs. PDII: 1.27 )
Ranked among companies with meaningful Current Ratio only.
PDII' s 10-Year Current Ratio Range
Min: 0.88  Med: 2.46 Max: 6.06
Current: 1.27
0.88
6.06
Quick Ratio 1.27
PDII's Quick Ratio is ranked lower than
58% of the 686 Companies
in the Global Business Services industry.

( Industry Median: 1.41 vs. PDII: 1.27 )
Ranked among companies with meaningful Quick Ratio only.
PDII' s 10-Year Quick Ratio Range
Min: 0.88  Med: 2.46 Max: 6.06
Current: 1.27
0.88
6.06
Days Sales Outstanding 38.94
PDII's Days Sales Outstanding is ranked higher than
71% of the 606 Companies
in the Global Business Services industry.

( Industry Median: 56.10 vs. PDII: 38.94 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDII' s 10-Year Days Sales Outstanding Range
Min: 4.74  Med: 38.15 Max: 81.74
Current: 38.94
4.74
81.74

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.25
PDII's Price/Median PS Value is ranked higher than
98% of the 660 Companies
in the Global Business Services industry.

( Industry Median: 1.17 vs. PDII: 0.25 )
Ranked among companies with meaningful Price/Median PS Value only.
PDII' s 10-Year Price/Median PS Value Range
Min: 0.18  Med: 1.16 Max: 5.03
Current: 0.25
0.18
5.03
Earnings Yield (Greenblatt) (%) -44.97
PDII's Earnings Yield (Greenblatt) (%) is ranked lower than
95% of the 725 Companies
in the Global Business Services industry.

( Industry Median: 4.80 vs. PDII: -44.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PDII' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -44.97  Med: 58.85 Max: 33126.9
Current: -44.97
-44.97
33126.9

Business Description

Industry: Business Services » Business Services
Compare:ADP, G, ENV, CMPGY, SGSOY » details
Traded in other countries:PF4.Germany,
PDI Inc was incorporated in Delaware just prior to its initial public offering in May 1998. The Company is a provider of outsourced commercial services to pharmaceutical, biotechnology and healthcare companies in the United States. It is a provider of outsourced sales teams that target healthcare providers, offering a range of complementary sales support services. The Company operates in three segments: Sales Services, Marketing Services and Product Commercialization segment. Sales Services segment focuses primarily on product detailing, and includes its outsourced sales teams and EngageCE business unit. Product detailing involves a sales representative meeting face-to-face with targeted physicians and other healthcare decision makers to provide a technical review of the product being promoted and deliver marketing materials, including samples. Marketing Services segment includes two business units: Group DCA; and PDI Voice (Voice). Group DCA's business is focused on the creation, design and implementation of interactive digital communications, including its e-detailing programs to the healthcare community on behalf of its pharmaceutical, biotechnology and healthcare customers. Voice's business is focused on the creation of teledetailing programs that are executed via tele-representatives. Product Commercialization Services segment includes its efforts related to its two collaboration agreements entered into to become a commercialization company for the molecular diagnostics industry through its Interpace Diagnostics entity; and its Interpace BioPharma business unit.
» More Articles for PDII

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: PDI Inc, RCS Capital Corp, Providence Service Corp. Nov 30 2014 
Six Sells in Review - The Charles Brandes Third Quarter Update Nov 14 2013 
Six Royce Reductions in Third Quarter Oct 09 2013 
PDI Inc. Reports Operating Results (10-Q) Aug 04 2010 
PDI Inc. Reports Operating Results (10-Q) May 06 2010 
PDI Inc. Reports Operating Results (10-Q) Nov 05 2009 
PDI Inc. (PDII) CEO Nancy Lurker buys 9,960 Shares Aug 18 2009 
PDI Inc. Reports Operating Results (10-Q) May 08 2009 
Weekly highlight of CFO buys: W.R. Grace & Co. (GRA), PDI Inc. (PDII), Brandywine Realty Trust (BDN) Dec 07 2008 

More From Other Websites
PDI INC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders Jun 09 2015
PDI INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 08 2015
DMCI PDI files fixed rate retail bonds to SEC May 25 2015
PDI INC Financials May 22 2015
Interpace Diagnostics Announces New Data Supporting Use of BarreGen™, a Molecular Test for... May 18 2015
Interpace Diagnostics Announces New Data Supporting Use of BarreGen™, a Molecular Test for... May 18 2015
10-Q for PDI, Inc. May 14 2015
Interpace Diagnostics Presents New Data at American Association of Clinical Endocrinologists (AACE)... May 14 2015
Interpace Diagnostics Presents New Data at American Association of Clinical Endocrinologists (AACE)... May 14 2015
PDI Reports 20% First Quarter 2015 Revenue Growth May 12 2015
PDI INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and... May 12 2015
PDI Reports 20% First Quarter 2015 Revenue Growth May 12 2015
Q1 2015 PDI Inc Earnings Release - After Market Close May 12 2015
PDI, Inc. to Report 2015 First Quarter Financial Results Apr 23 2015
PDI, Inc. to Report 2015 First Quarter Financial Results Apr 23 2015
PDI, Inc. Subsidiary Interpace Diagnostics Sets New Precedent with Launch of ThyraMIRTM, First and... Apr 15 2015
PDI, Inc. Subsidiary Interpace Diagnostics Sets New Precedent with Launch of ThyraMIR™, First and... Apr 15 2015
PDI, Inc. Subsidiary Interpace Diagnostics Sets New Precedent with Launch of ThyraMIR™, First and... Apr 15 2015
Endesa CHILE: PUBLIC STATEMENT FOR PROCEEDINGS OF PDI BY CASE BOCAMINA Apr 09 2015
2015 Registration Form* - Version 2 Apr 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK